Challenging the future of siRNA therapeutics against cancer: the crucial role of nanotechnology.
about
Scalable preparation of poly(ethylene glycol)-grafted siRNA-loaded lipid nanoparticles using a commercially available fluidic device and tangential flow filtration.Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment.Effective Small Interfering RNA Therapy to Treat CLCN7-dependent Autosomal Dominant Osteopetrosis Type 2.Preclinical Safety Evaluation in Rats of a Polymeric Matrix Containing an siRNA Drug Used as a Local and Prolonged Delivery System for Pancreatic Cancer Therapy.The CRISPR/Cas system inhibited the pro-oncogenic effects of alternatively spliced fibronectin extra domain A via editing the genome in salivary adenoid cystic carcinoma cells.De novo design of functional oligonucleotides with acyclic scaffolds.
P2860
Challenging the future of siRNA therapeutics against cancer: the crucial role of nanotechnology.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Challenging the future of siRN ...... rucial role of nanotechnology.
@en
type
label
Challenging the future of siRN ...... rucial role of nanotechnology.
@en
prefLabel
Challenging the future of siRN ...... rucial role of nanotechnology.
@en
P2093
P2860
P50
P1476
Challenging the future of siRN ...... rucial role of nanotechnology.
@en
P2093
João Nuno Moreira
Lígia Catarina Gomes-da-Silva
Sérgio Simões
P2860
P2888
P304
P356
10.1007/S00018-013-1502-2
P577
2013-11-13T00:00:00Z